Abstract:What's new? Metastatic gastric cancer (GC) remains an elusive disease to treat, even after intensive therapy with multidisciplinary approaches. The identification of a novel therapeutic target involved in malignant GC could help overcome this challenge. Here, the authors searched for cell surface membrane receptors that could serve as targets for therapeutic antibodies, with analyses highlighting natriuretic peptide receptor 1 (NPR1). Experiments in cells showed that siRNA‐mediated suppression of NPR1 inhibits GC growth and induces apoptosis. In a mouse xenograft model of disseminated GC, intraperitoneal administration of anti‐NPR1 antibody reduced tumor mass. Thus, NPR1 may be a promising therapeutic target in metastatic GC. Despite recent advances in the development of therapeutic antibodies, the prognosis of unresectable or metastatic gastric cancer (GC) remains poor. Here, we searched for genes involved in the malignant phenotype of GC and investigated the potential of one candidate gene to serve as a novel therapeutic target. Analysis of transcriptome datasets of GC identified natriuretic peptide receptor 1 (NPR1), a plasma membrane protein, as a potential target. We employed a panel of human GC cell lines and gene‐specific small interfering RNA‐mediated NPR1 silencing to investigate the roles of NPR1 in malignancy‐associated functions and intracellular signaling pathways. We generated an anti‐NPR1 polyclonal antibody and examined its efficacy in a mouse xenograft model of GC peritoneal dissemination. Associations between NPR1 expression in GC tissue and clinicopathological factors were also evaluated. NPR1 mRNA was significantly upregulated in several GC cell lines compared with normal epithelial cells. NPR1 silencing attenuated GC cell proliferation, invasion, and migration, and additionally induced the intrinsic apoptosis pathway associated with mitochondrial dysfunction and caspase activation via downregulation of BCL‐2. Administration of anti‐NPR1 antibody significantly reduced the number and volume of GC peritoneal tumors in xenografted mice. High expression of NPR1 mRNA in clinical GC specimens was associated with a significantly higher rate of postoperative recurrence and poorer prognosis. NPR1 regulates the intrinsic apoptosis pathway and plays an important role in promoting the GC malignant phenotype. Inhibition of NPR1 with antibodies may have potential as a novel therapeutic modality for unresectable or metastatic GC.

Natriuretic Peptide Receptor A As a Novel Target for Cancer

P-0033 Natriuretic Peptide Receptor a As a Novel Target for Gastric Cancer

Anp-Npra Signaling Pathway-A Potential Therapeutic Target for the Treatment of Malignancy

Impact Of Npr-A Expression In Gastric Cancer Cells

Pleiotropic Roles of Atrial Natriuretic Peptide in Anti-Inflammation and Anti-Cancer Activity

Natriuretic Peptide Receptor a Promotes Breast Cancer Development by Upregulating MMP9

The (pro)renin Receptor: a Novel Biomarker and Potential Therapeutic Target for Various Cancers

Natriuretic Peptide Receptor A Inhibition Suppresses Gastric Cancer Development Through Reactive Oxygen Species-Mediated G2/M Cell Cycle Arrest and Cell Death.

Expression of Natriuretic Peptide Receptor-a in Esophageal Squamous Cell Carcinomas and the Relationship with Tumor Invasion and Migration.

Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth via BCL‐2‐mediated intrinsic apoptosis

Natriuretic peptide receptor A signaling regulates stem cell recruitment and angiogenesis: a model to study linkage between inflammation and tumorigenesis.

Expression and Clinical Significance of Npra in Esophageal Squamous Cell Carcinoma

Natriuretic Peptide Receptor a Promotes Gastric Malignancy Through Angiogenesis Process.

Targeting neuropilin-1 interactions is a promising anti-tumor strategy

Role of Atrial Natriuretic Peptide Receptor in Inhibition of Laterally Spreading Tumors Via Wnt/β-catenin Signaling

Atrial natriuretic peptide modulates the proliferation of human gastric cancer cells via KCNQ1 expression.

A Promising New Cancer Marker: Long Noncoding RNA EGFR-AS1

Natriuretic Peptides: Another Tool For The Management Of Cancer?

Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells

Expression and clinical significance of NPR-A in non-small cell lung cancer